Stelios Papadopoulos
April 12, 2023 03:56 AM EDTUpdated 06:32 AM
Financing
Deals

SPAC led by Bio­gen chair­man Pa­padopou­los can't find a deal and will liq­ui­date

Kyle LaHucik

Senior Reporter

A SPAC formed two and a half years ago by out­go­ing Bio­gen chair­man Ste­lios Pa­padopou­los will shut­ter with­out find­ing a deal.

Tues­day af­ter the mar­ket …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Jim Wilson's Gem­ma­Bio rais­es $34M to com­mer­cial­ize gene ther­a­pies for rare dis­eases

A service from the Financial Times